Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells

Das, 2011, Lipoxins as biomarkers of lupus and other inflammatory conditions, Lipids Health Dis, 10, 76, 10.1186/1476-511X-10-76 Janakiram, 2011, Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer, Cancer Metastasis Rev, 30, 507, 10.1007/s10555-011-9311-2 Janakiram, 2009, Role of lipoxins and resolvins as anti-inflammatory and proresolving mediators in colon cancer, Curr Mol Med, 9, 565, 10.2174/156652409788488748 Chen, 2008, Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death, J Exp Med, 205, 2791, 10.1084/jem.20080767 Serhan, 2008, Anti-inflammatory and proresolving lipid mediators, Annu Rev Pathol, 3, 279, 10.1146/annurev.pathmechdis.3.121806.151409 Kieran, 2012, The VEGF pathway in cancer and disease: responses, resistance, and the path forward, Cold Spring Harb Perspect Med, 2, a006593, 10.1101/cshperspect.a006593 Claesson-Welsh, 2012, Receptor talk and tumor cell walk in glioblastoma, Cancer Cell, 22, 1, 10.1016/j.ccr.2012.06.011 Chang, 1994, Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma, Science, 266, 1865, 10.1126/science.7997879 Fiorelli, 1998, gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?, Blood, 91, 956 Samaniego, 1998, Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development, Am J Pathol, 152, 1433 Radu, 2013, Kaposi sarcoma, Arch Pathol Lab Med, 137, 289, 10.5858/arpa.2012-0101-RS Cancian, 2013, Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming, Trends Cell Biol, 23, 421, 10.1016/j.tcb.2013.04.001 Albini, 1994, Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2, AIDS, 8, 1237, 10.1097/00002030-199409000-00004 Albini, 2010, Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention, J Natl Cancer Inst, 102, 14, 10.1093/jnci/djp440 Albini, 2001, Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine, Cancer Res, 61, 8171 Albini, 1995, Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine, Int J Cancer, 61, 121, 10.1002/ijc.2910610121 Morini, 1999, The role of the thiol N-acetylcysteine in the prevention of tumor invasion and angiogenesis, Int J Biol Markers, 14, 268, 10.1177/172460089901400413 Boshoff, 2002, Kaposi's sarcoma biology, IUBMB Life, 53, 259, 10.1080/15216540212645 Dupin, 1999, Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma, Proc Natl Acad Sci U S A, 96, 4546, 10.1073/pnas.96.8.4546 Sharp, 2002, K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function, J Virol, 76, 802, 10.1128/JVI.76.2.802-816.2002 Wang, 2002, Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin, EMBO J, 21, 2602, 10.1093/emboj/21.11.2602 Jin, 2009, Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators, Invest Ophthalmol Vis Sci, 50, 4743, 10.1167/iovs.08-2462 Romano, 2010, Lipoxin and aspirin-triggered lipoxins, ScientificWorldJournal, 10, 1048, 10.1100/tsw.2010.113 Cezar-de-Mello, 2006, Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly, Oncogene, 25, 122, 10.1038/sj.onc.1209002 Liu, 2002, Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line, J Biol Chem, 277, 50081, 10.1074/jbc.M201095200 Liu, 2010, Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model, Biochem Pharmacol, 79, 880, 10.1016/j.bcp.2009.10.025 Khovidhunkit, 2004, Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host, J Lipid Res, 45, 1169, 10.1194/jlr.R300019-JLR200 Takano, 1997, Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors, J Exp Med, 185, 1693, 10.1084/jem.185.9.1693 Brown, 2004, Cyclooxygenase-2 in lung carcinogenesis and chemoprevention: Roger S. Mitchell lecture, Chest, 125, 134S, 10.1378/chest.125.5_suppl.134S-a George Paul, 2010, Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen, Cancer Res, 70, 3697, 10.1158/0008-5472.CAN-09-3934 Sharma-Walia, 2012, COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma-associated herpes virus oncoprotein-v-FLIP, Oncogenesis, 1, e5, 10.1038/oncsis.2012.5 Paul, 2011, Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma, PLoS One, 6, e24379, 10.1371/journal.pone.0024379 Sharma-Walia, 2010, Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion, PLoS Pathog, 6, e1000777, 10.1371/journal.ppat.1000777 Sharma-Walia, 2006, Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression, J Virol, 80, 6534, 10.1128/JVI.00231-06 Sharma-Walia, 2014, The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis, J Virol, 88, 2131, 10.1128/JVI.02786-13 Krishnan, 2006, Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells, J Virol, 80, 1167, 10.1128/JVI.80.3.1167-1180.2006 Raghu, 2009, Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells, J Virol, 83, 4895, 10.1128/JVI.02498-08 Jack, 2000, Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia, Hum Pathol, 31, 1146, 10.1053/hupa.2000.16670 Muga, 2000, 8S-Lipoxygenase products activate peroxisome proliferator-activated receptor alpha and induce differentiation in murine keratinocytes, Cell Growth Differ, 11, 447 Smith, 2000, Cyclooxygenases: structural, cellular, and molecular biology, Annu Rev Biochem, 69, 145, 10.1146/annurev.biochem.69.1.145 Vane, 1998, Cyclooxygenases 1 and 2, Annu Rev Pharmacol Toxicol, 38, 97, 10.1146/annurev.pharmtox.38.1.97 Dubois, 2000, Review article: cyclooxygenase—a target for colon cancer prevention, Aliment Pharmacol Ther, 14, 64, 10.1046/j.1365-2036.2000.014s1064.x Claria, 2006, Regulation of cell proliferation and apoptosis by bioactive lipid mediators, Recent Pat Anticancer Drug Discov, 1, 369, 10.2174/157489206778776961 Neufeld, 1996, Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants, Cancer Metastasis Rev, 15, 153, 10.1007/BF00437467 Neufeld, 1999, Vascular endothelial growth factor (VEGF) and its receptors, FASEB J, 13, 9, 10.1096/fasebj.13.1.9 Poltorak, 1997, VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix, J Biol Chem, 272, 7151, 10.1074/jbc.272.11.7151 Poltorak, 2000, The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases, Herz, 25, 126, 10.1007/PL00001950 Labrecque, 2003, Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol, Mol Biol Cell, 14, 334, 10.1091/mbc.E02-07-0379 Muralidhar, 2000, Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12), J Clin Virol, 16, 203, 10.1016/S1386-6532(99)00081-5 Boshoff, 1998, Kaposi's sarcoma-associated herpesvirus, Adv Cancer Res, 75, 57, 10.1016/S0065-230X(08)60739-3 Gaidano, 1996, Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions, Leukemia, 10, 1237 Dittmer, 1999, Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice, J Exp Med, 190, 1857, 10.1084/jem.190.12.1857 Sturzl, 1997, Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma, Int J Cancer, 72, 68, 10.1002/(SICI)1097-0215(19970703)72:1<68::AID-IJC10>3.0.CO;2-6 Vannini, 2007, The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent, Mol Cancer Ther, 6, 3139, 10.1158/1535-7163.MCT-07-0451 Tosetti, 2002, Angioprevention: angiogenesis is a common and key target for cancer chemopreventive agents, FASEB J, 16, 2, 10.1096/fj.01-0300rev Aluigi, 2000, Antiapoptotic and antigenotoxic effects of N-acetylcysteine in human cells of endothelial origin, Anticancer Res, 20, 3183 D'Agostini, 1998, Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice, Int J Oncol, 13, 217 Cai, 1999, N-acetylcysteine inhibits endothelial cell invasion and angiogenesis, Lab Invest, 79, 1151 De Flora, 1996, Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models, Int J Cancer, 67, 842, 10.1002/(SICI)1097-0215(19960917)67:6<842::AID-IJC14>3.0.CO;2-3 Serhan, 2008, Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators, Nat Rev Immunol, 8, 349, 10.1038/nri2294 Koch, 2012, Signal transduction by vascular endothelial growth factor receptors, Cold Spring Harb Perspect Med, 2, a006502, 10.1101/cshperspect.a006502 Dubois, 1998, Cyclooxygenase in biology and disease, FASEB J, 12, 1063, 10.1096/fasebj.12.12.1063 Williams, 1999, The role of cyclooxygenases in inflammation, cancer, and development, Oncogene, 18, 7908, 10.1038/sj.onc.1203286 Dannenberg, 2003, Targeting cyclooxygenase-2 in human neoplasia: rationale and promise, Cancer Cell, 4, 431, 10.1016/S1535-6108(03)00310-6 Tager, 2003, BLT1 and BLT2: the leukotriene B(4) receptors, Prostaglandins Leukot Essent Fatty Acids, 69, 123, 10.1016/S0952-3278(03)00073-5 Claesson, 2009, On the biosynthesis and biological role of eoxins and 15-lipoxygenase-1 in airway inflammation and Hodgkin lymphoma, Prostaglandins Other Lipid Mediat, 89, 120, 10.1016/j.prostaglandins.2008.12.003 Claesson, 2008, Hodgkin Reed-Sternberg cells express 15-lipoxygenase-1 and are putative producers of eoxins in vivo: novel insight into the inflammatory features of classical Hodgkin lymphoma, FEBS J, 275, 4222, 10.1111/j.1742-4658.2008.06570.x Claesson, 1992, Leukotriene B4 in the immune system, Int J Immunopharmacol, 14, 441, 10.1016/0192-0561(92)90174-J Sharma-Walia, 2010, Nfat and Creb regulate Kaposi's sarcoma associated herpes virus (KSHV) induced cyclooxygenase-2 (COX-2), J Virol, 84, 12733, 10.1128/JVI.01065-10 Sin, 2012, Cytokine homologs of human gammaherpesviruses, J Interferon Cytokine Res, 32, 53, 10.1089/jir.2011.0083 Foster, 2000, An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus, Blood, 96, 2562, 10.1182/blood.V96.7.2562 Qin, 2010, Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes, J Leukoc Biol, 87, 25, 10.1189/jlb.0409251 Miles, 1990, AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6, Proc Natl Acad Sci U S A, 87, 4068, 10.1073/pnas.87.11.4068 Li, 2003, IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis, J Immunol, 170, 3369, 10.4049/jimmunol.170.6.3369 Sharma-Walia, 2005, ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection, J Virol, 79, 10308, 10.1128/JVI.79.16.10308-10329.2005 Murakami-Mori, 1999, J Immunol, 162, 3672, 10.4049/jimmunol.162.6.3672 Chandran, 2010, Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells, J Virol, 84, 2188, 10.1128/JVI.01334-09 Chang, 2000, Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication, Virology, 266, 17, 10.1006/viro.1999.0077 Sadagopan, 2007, Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression, J Virol, 81, 3949, 10.1128/JVI.02333-06 Badescu, 2014, Akt pathway protein expression in gastrointestinal Kaposi sarcomas: relevance for tumor biology, APMIS, 122, 518, 10.1111/apm.12190 Sodhi, 2004, Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor, Proc Natl Acad Sci U S A, 101, 4821, 10.1073/pnas.0400835101 Bhatt, 2012, AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV, Front Immunol, 3, 401 Dyson, 2010, Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1, J Biol Chem, 285, 37491, 10.1074/jbc.M110.159103 Wang, 2004, Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway, J Virol, 78, 4248, 10.1128/JVI.78.8.4248-4267.2004 Cheng, 2002, The ephrins and Eph receptors in angiogenesis, Cytokine Growth Factor Rev, 13, 75, 10.1016/S1359-6101(01)00031-4 He, 2012, Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2, Cancer Res, 72, 3582, 10.1158/0008-5472.CAN-11-2876 Ojala, 2014, Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation, Semin Cancer Biol, 26, 69, 10.1016/j.semcancer.2014.01.008 Masood, 2005, Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium, Blood, 105, 1310, 10.1182/blood-2004-03-0933 Wang, 2004, The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors, Cancer Res, 64, 2774, 10.1158/0008-5472.CAN-03-3653 Ford, 2004, Vascular endothelial growth factor augments human herpesvirus-8 (HHV-8/KSHV) infection, Cancer Biol Ther, 3, 876, 10.4161/cbt.3.9.1054 Sivakumar, 2008, Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications, J Virol, 82, 1759, 10.1128/JVI.00873-07 Groger, 2004, IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells, J Immunol, 173, 7161, 10.4049/jimmunol.173.12.7161